Mouse CXCL5 (ENA-78) ELISA

Catalog Number:
DIY1373M
Availability:
In stock
Application:
ELISA
100% Homology:
Mus musculus (house mouse)

Components

UsageQuantityComponentSize
Detection Antibody50 µgKPB1372M-050
Standard5 µgRP1084M-005
Capture Antibody100 µgKP1371M-1001 Pack (<= 10 Plates)
Capture Antibody100 µg X 2KP1371M-1001 Pack (<= 20 Plates)
  • The Mouse CXCL5 (Chemokine (C-X-C motif) ligand 5, also known as LIX) ELISA is designed for the quantitative measurement of CXCL5 in cell culture supernatants from mice (Mus musculus) and can also be used to measure CXCL5 in a variety of biological sample types reported in the literature, including serum, plasma, whole blood, and tissue lysates from organs such as lung, spleen, liver, and bone marrow. While the kit is optimized for cell culture supernatants, minor modifications to the protocol may be required when measuring CXCL5 in other sample types to ensure optimal sensitivity and accuracy, allowing researchers to adjust buffers, antibody concentrations, incubation times, temperatures, and other assay conditions as needed. CXCL5 is a chemokine primarily produced by activated macrophages, epithelial cells, and neutrophils and plays a central role in neutrophil recruitment, inflammation, and host defense against infection. In the mouse animal model, CXCL5 is widely studied in the context of acute inflammation, infectious disease, immunology, and tissue injury, where its expression reflects chemokine-mediated immune activation and neutrophil mobilization. Measurement of CXCL5 provides valuable insight into immune signaling, inflammatory responses, disease progression, and the efficacy of therapeutic interventions, with reported levels in mice typically detected at low picogram-per-milliliter concentrations under basal conditions (~10-150 pg/mL in serum or plasma) and increasing during immune challenge, infection, or inflammatory stimulation, depending on sample type and experimental context. The kit contains a capture antibody, detection antibody, and recombinant mouse CXCL5 protein standard for assay development, and these antibodies have been validated to function together in an ELISA format using the provided standard. The quantities of kit components are not matched, and individual components may be purchased separately. This product is for research use only and is manufactured in the USA.
Storage Conditions2°C to 8°C or -20°C
Country Of OriginUSA
Mouse CXCL5 (C-X-C motif chemokine ligand 5), also known as LIX (lipopolysaccharide-induced CXC chemokine), is a proinflammatory chemokine belonging to the ELR⁺ CXC chemokine family, which includes CXCL1 (KC), CXCL2 (MIP-2), and CXCL3 that regulate neutrophil recruitment during inflammatory responses. In mice (Mus musculus), CXCL5 is produced by macrophages, epithelial cells, endothelial cells, fibroblasts, and other tissue cells in response to bacterial products such as lipopolysaccharide (LPS), proinflammatory cytokines including IL-1β and TNF-α, and tissue injury. CXCL5 signals primarily through the chemokine receptor CXCR2, expressed on neutrophils and other innate immune cells, promoting chemotaxis, activation, and migration of neutrophils to sites of infection or inflammation. In murine immunology, CXCL5 plays an important role in innate immune defense and inflammatory signaling, particularly in the lung and gastrointestinal tract. Mouse CXCL5 has been extensively studied in experimental models of acute lung injury and bacterial pneumonia, where CXCL5-mediated recruitment of neutrophils contributes to pulmonary inflammation and host defense against respiratory pathogens. Because mice are widely used for genetic and experimental models of inflammatory disease, CXCL5 has been important for understanding neutrophil trafficking, chemokine signaling, and mechanisms of inflammatory tissue injury and host protection.

Please choose a size to see price


Reagents for Animal Model and Animal Health Research

Kingfisher Biotech, Inc.
1000 Westgate Drive
Suite 123
Saint Paul, MN 55114

Phone: 651-646-0089
Fax: 651-646-0095

Animal Antibodies

Newsletter

"